PRTAV

Prothena Corp. Plc - Ordinary Shares (MM) (PRTAV)

Prothena Corp. Plc - Ordinary Shares (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PRTAV

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/10/28	05:05	GlobeNewswire Inc.	Prothena to Report Third Quarter 2022 Financial Results on November 3rd	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/09/02	05:20	GlobeNewswire Inc.	Prothena to Participate in Upcoming Healthcare Conferences	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/09/02	05:05	GlobeNewswire Inc.	Prothena Announces Appointment of Biotechnology Industry Leader Helen S. Kim to its Board of Directors	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/08/09	05:05	GlobeNewswire Inc.	Prothena Reports Second Quarter 2022 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/08/03	05:05	GlobeNewswire Inc.	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/08/02	05:05	GlobeNewswire Inc.	Prothena to Report Second Quarter 2022 Financial Results on August 8th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/07/02	05:16	GlobeNewswire Inc.	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/06/03	05:05	GlobeNewswire Inc.	Prothena to Participate in Jefferies Healthcare Conference	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/05/06	05:05	GlobeNewswire Inc.	Prothena Reports First Quarter 2022 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/04/29	05:05	GlobeNewswire Inc.	Prothena to Report First Quarter 2022 Financial Results on May 5th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/04/26	21:30	GlobeNewswire Inc.	Prothena Receives FDA Fast Track Designation for PRX012, a Next-Generation Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/03/28	21:30	GlobeNewswire Inc.	Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under Investigation for the Treatment of Alzheimer’s Disease	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/03/22	05:05	GlobeNewswire Inc.	Prothena to Participate in Stifel 2022 Virtual CNS Days	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/03/16	18:30	GlobeNewswire Inc.	Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/02/18	06:05	GlobeNewswire Inc.	Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidance and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2022/02/11	06:05	GlobeNewswire Inc.	Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference Call on February 17, 2022	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/11/30	06:05	GlobeNewswire Inc.	Prothena to Participate in JMP Securities Hematology and Oncology Summit	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/11/05	05:05	GlobeNewswire Inc.	Prothena Reports Third Quarter 2021 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/10/29	05:05	GlobeNewswire Inc.	Prothena to Report Third Quarter 2021 Financial Results on November 4th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/10/02	05:30	GlobeNewswire Inc.	Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/10/02	05:05	GlobeNewswire Inc.	Prothena Announces Executive Appointments	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/09/04	05:05	GlobeNewswire Inc.	Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/09/02	05:05	GlobeNewswire Inc.	Prothena to Participate in Upcoming September Healthcare Conferences	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/08/06	05:05	GlobeNewswire Inc.	Prothena Reports Second Quarter 2021 Financial Results and Business Highlights	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/07/30	05:05	GlobeNewswire Inc.	Prothena to Report Second Quarter 2021 Financial Results on August 5th	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/07/26	22:00	GlobeNewswire Inc.	Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association International Conference 2021	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/07/21	05:05	GlobeNewswire Inc.	Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association International Confer...	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/07/12	20:00	GlobeNewswire Inc.	Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/06/24	21:30	GlobeNewswire Inc.	Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global Neuroscience Research and ...	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)
2021/06/11	03:18	GlobeNewswire Inc.	Prothena to Participate in JMP Securities Life Sciences Conference on June 16	NASDAQ:PRTAV	Prothena Corp. Plc - Ordinary Shares (MM)